- R&D
Onward awarded $1.1M grant from the Christopher & Dana Reeve Foundation to advance BCI research
Onward Medical revealed that it has received a major grant from the Christopher & Dana Reeve Foundation to continue with BCI research. This $1.1M...Germany to Provide 100,000 Mpox Vaccine Doses to Combat Outbreak in Africa
Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to help combat the ongoing outbreak in Africa, a government spokesperson...Covid Symptoms Prevented by New Drug Used on Mice, No Risk of Resistance
Research findings from new studies show that organ damage resulting from Covid-19 can be averted by an antioxidant enzyme that shields a cell’s mitochondria....Novo’s Wegovy leads to women losing more weight than men
In a study conducted on women and men with heart failure compared to a placebo, and presented at the American Diabetes Association’s 2024 research...
- Clinical
Phase 2/3 of Athira Trial for Alzheimer’s Fails
Athira Pharma’s Phase 2/3 Alzheimer’s disease trial has ended in failure. The trial revealed that fosgonimeton performed no better than a placebo for the...Sanofi’s Tolebrutinib faces defeat in 2 out of 3 phase 3 MS trials
Sanofi has announced that tolebrutinib, a BTK inhibitor, failed in two out of three Phase 3 trials. Tolebrutinib was being evaluated across two forms...Novo Nordisk Says Goodbye to GLP-1/GIP MASH Prospect
Novo Nordisk has decided to discontinue the development of a medication candidate that it had highlighted earlier this year as an intriguing component of...Agios Fails to Reach Primary Objective in Pediatric Study
In spite of the fact that it failed to meet the primary goal in a pediatric research, Agios has stated that it is continuing...
- Manufacturing
Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production
It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a fierce battle as they work towards scaling production to meet...French Company Orano Med Opens New Radiation Production Facility Near Indianapolis
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...Gerresheimer Increases the Capabilities of Medical Systems in the USA
Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
- Commercial
Allist Secures Leading Role in China’s KRAS Inhibitor Market with $21M Jacobio Deal
Shanghai Allist Pharmaceuticals has significantly bolstered its position in China's burgeoning KRAS inhibitor market through a strategic agreement with Jacobio Pharma. This deal, valued...Siemens Healthineers to Acquire Novartis’ European Radiodiagnostic Production Network
As part of its strategy to expand PET imaging capabilities, Siemens Healthineers will acquire the radiodiagnostic production and distribution platforms affiliated with Novartis’ Advanced...McKesson Invests $2.5B to Acquire Majority Stake in Florida-Based Community Oncology
McKesson has planned to enhance its oncology platform with a significant investment of approximately $2.5 billion into the business and administrative services subsidiary of...
- Technology
Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...AI Firm Formation Bags $372 Series D Funding
In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort
Mohsin Riaz - 0California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part...Musk’s Neuralink Aiming to Enroll Three Patients in Brain Implant Research
According to the information on the clinical trials database maintained by the U.S. government, Neuralink, the brain-chip firm owned by Elon Musk, intends to...
- Regulatory
Illumina Gets Favorable Decision Regarding Grail Acquisition
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...Emergent Bio’s Smallpox Vaccine Gains FDA Approval for Mpox
Emergent BioSolutions' smallpox vaccine has received expanded approval from the U.S. Food and Drug Administration (FDA) for use in individuals at high risk of...Bavarian Nordic Receives Mpox Vaccine Green Light From Singapore
Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by Singapore's Health Sciences Authority (HSA) for the prevention of smallpox and mpox...Ascendis Receives a Grudging FDA Approval for Yorvipath, a Hormone Replacement Treatment
Ascendis Pharma should be in a good position to launch its hormone replacement therapy for hypoparathyroidism in the U.S. market, as it received FDA...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
Onward awarded $1.1M grant from the Christopher & Dana Reeve Foundation to advance BCI research
Onward Medical revealed that it has received a major grant from the Christopher & Dana Reeve Foundation to continue with BCI research. This $1.1M...Germany to Provide 100,000 Mpox Vaccine Doses to Combat Outbreak in Africa
Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to help combat the ongoing outbreak in Africa, a government spokesperson...Covid Symptoms Prevented by New Drug Used on Mice, No Risk of Resistance
Research findings from new studies show that organ damage resulting from Covid-19 can be averted by an antioxidant enzyme that shields a cell’s mitochondria....Novo’s Wegovy leads to women losing more weight than men
In a study conducted on women and men with heart failure compared to a placebo, and presented at the American Diabetes Association’s 2024 research...
- Clinical
Phase 2/3 of Athira Trial for Alzheimer’s Fails
Athira Pharma’s Phase 2/3 Alzheimer’s disease trial has ended in failure. The trial revealed that fosgonimeton performed no better than a placebo for the...Sanofi’s Tolebrutinib faces defeat in 2 out of 3 phase 3 MS trials
Sanofi has announced that tolebrutinib, a BTK inhibitor, failed in two out of three Phase 3 trials. Tolebrutinib was being evaluated across two forms...Novo Nordisk Says Goodbye to GLP-1/GIP MASH Prospect
Novo Nordisk has decided to discontinue the development of a medication candidate that it had highlighted earlier this year as an intriguing component of...Agios Fails to Reach Primary Objective in Pediatric Study
In spite of the fact that it failed to meet the primary goal in a pediatric research, Agios has stated that it is continuing...
- Manufacturing
Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production
It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a fierce battle as they work towards scaling production to meet...French Company Orano Med Opens New Radiation Production Facility Near Indianapolis
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...Gerresheimer Increases the Capabilities of Medical Systems in the USA
Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
- Commercial
Allist Secures Leading Role in China’s KRAS Inhibitor Market with $21M Jacobio Deal
Shanghai Allist Pharmaceuticals has significantly bolstered its position in China's burgeoning KRAS inhibitor market through a strategic agreement with Jacobio Pharma. This deal, valued...Siemens Healthineers to Acquire Novartis’ European Radiodiagnostic Production Network
As part of its strategy to expand PET imaging capabilities, Siemens Healthineers will acquire the radiodiagnostic production and distribution platforms affiliated with Novartis’ Advanced...McKesson Invests $2.5B to Acquire Majority Stake in Florida-Based Community Oncology
McKesson has planned to enhance its oncology platform with a significant investment of approximately $2.5 billion into the business and administrative services subsidiary of...
- Technology
Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...AI Firm Formation Bags $372 Series D Funding
In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort
Mohsin Riaz - 0California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part...Musk’s Neuralink Aiming to Enroll Three Patients in Brain Implant Research
According to the information on the clinical trials database maintained by the U.S. government, Neuralink, the brain-chip firm owned by Elon Musk, intends to...
- Regulatory
Illumina Gets Favorable Decision Regarding Grail Acquisition
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...Emergent Bio’s Smallpox Vaccine Gains FDA Approval for Mpox
Emergent BioSolutions' smallpox vaccine has received expanded approval from the U.S. Food and Drug Administration (FDA) for use in individuals at high risk of...Bavarian Nordic Receives Mpox Vaccine Green Light From Singapore
Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by Singapore's Health Sciences Authority (HSA) for the prevention of smallpox and mpox...Ascendis Receives a Grudging FDA Approval for Yorvipath, a Hormone Replacement Treatment
Ascendis Pharma should be in a good position to launch its hormone replacement therapy for hypoparathyroidism in the U.S. market, as it received FDA...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
Moderna skin cancer medication gets FDA approval
Moderna announced that U.S. authorities have approved its experimental personalised skin cancer...
Bristol Myers Squibb Launches Sotyktu Initiative to Provide a ‘Comprehensive Insight’ into Living with Psoriasis
Bristol Myers Squibb is actively working to shed light on the intricate...
Alnylam Reports Successful Results in Highly Anticipated Heart Drug Study
An experimental medication has demonstrated potential as an aid for certain people with a...
Must Read
Phase 2/3 of Athira Trial for Alzheimer’s Fails
Athira Pharma’s Phase 2/3 Alzheimer’s disease trial has ended in failure. The trial revealed...
Sanofi’s Tolebrutinib faces defeat in 2 out of 3 phase 3 MS trials
Sanofi has announced that tolebrutinib, a BTK inhibitor, failed in two out of three...
Illumina Gets Favorable Decision Regarding Grail Acquisition
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com